RxDoctor Payments Data

Patricia Odham

Family · Wilmington, NCNPI 1750457024

Payments from drug & device makers

$6,828in general payments, 2019–2025

Across 277 payments — averaging $24.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$1K
  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$542
  • Alkermes, Inc.$528
  • Neurocrine Biosciences, Inc.$464
  • Johnson & Johnson$355
  • plus $3K from 24 others

What the payments were for

  • Food & beverage$6,77799%
  • Education$511%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,828 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole18$24,518
TrintellixVortioxetine Hydrobromide11$7,254
Bupropion XlBupropion Hcl18$346
Escitalopram Oxalate25$301
Prazosin Hcl12$238
Duloxetine Hcl16$180
Hydroxyzine Pamoate12$161
Propranolol Hcl15$153
Sertraline Hcl12$90
Fluoxetine Hcl15$90
Trazodone Hcl23$88
Mirtazapine12$87

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$297$24,51818 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$60$7,25411 claims
Almatica Pharma LLCSertraline Hcl$126$9012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,522 family providers in North Carolina.

Other family in Wilmington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →